Endra Life Sciences Inc (NDRA) Stock Price, Quote & News

Company Profile

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 734 335 0468

Website: endrainc.com

Address:

3600 Green Court, Suite 350, Ann Arbor, United States

jjstock99 Jun. 17 at 2:42 PM

$NDRA $CGBS Its coming ...

0 · Reply

LioGod Jun. 13 at 12:04 AM

$NDRA setting another pump?

0 · Reply

Bazzzigar Jun. 12 at 4:59 PM

$NDRA APDN WINT

0 · Reply

Lurker_Investor Jun. 10 at 5:36 AM

$NDRA This is fucked

0 · Reply

Jess_Inv Jun. 4 at 4:09 PM

$NDRA Patient wins ! Still waiting for volume to come in !

1 · Reply

johnlesser Jun. 4 at 4:03 PM

$NDRA Only takes a spark to get this fire going, which could turn into a volcano.

0 · Reply

ahTony Jun. 3 at 11:32 PM

$CDT $ALZN $PTIX $NDRA current sub 1 million float stocks on my watchlist.

0 · Reply

Molten_cpr Jun. 3 at 1:09 AM

$NDRA

0 · Reply

InvestorTechnical Jun. 2 at 4:48 PM

$NDRA remember me at $3.14 avg of 5,000 shares . Squeeze will happen and everyone pour in higher then me. $SPY $QQQ .. gonna be like a $PTIX when it ran to $14S from 3s

0 · Reply

Jess_Inv Jun. 2 at 4:03 PM

$NDRA $BEAM $NTLA bio tech are doing well today.

0 · Reply

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

May 15, 2025, 4:05 PM EDT - 4 weeks ago

ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results

Mar 31, 2025, 8:05 AM EDT - 2 months ago

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

Mar 31, 2025, 8:00 AM EDT - 2 months ago

ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update

Nov 22, 2024, 8:00 AM EST - 7 months ago

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Nov 15, 2024, 9:24 AM EST - 7 months ago

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Nov 12, 2024, 8:00 AM EST - 7 months ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting® 2024

Nov 6, 2024, 8:00 AM EST - 8 months ago

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Oct 22, 2024, 8:00 AM EDT - 8 months ago

ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany

Aug 30, 2024, 8:54 AM EDT - 10 months ago

Data I/O And 2 Other Stocks Under $5 Executives Are Buying

DAIO

Aug 28, 2024, 4:17 PM EDT - 10 months ago

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Aug 22, 2024, 5:54 PM EDT - 10 months ago

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

Aug 22, 2024, 4:14 PM EDT - 10 months ago

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 16, 2024, 8:00 AM EDT - 10 months ago

ENDRA Life Sciences Announces Reverse Stock Split

Aug 13, 2024, 4:05 PM EDT - 11 months ago

ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024

Aug 13, 2024, 8:00 AM EDT - 11 months ago

ENDRA Life Sciences Announces Leadership Changes

Aug 7, 2024, 8:00 AM EDT - 11 months ago

ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14

Jun 4, 2024, 9:21 AM EDT - 1 year ago

ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering

Jun 4, 2024, 9:06 AM EDT - 1 year ago

AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit

May 20, 2024, 8:00 AM EDT - 1 year ago

ENDRA Provides Update Following In-person Meeting with FDA

May 14, 2024, 8:30 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update

May 7, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024

May 2, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents

Mar 28, 2024, 9:10 PM EDT - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 21, 2024, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024

Feb 27, 2024, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Installs First TAEUS System in the UK

Feb 21, 2024, 8:00 AM EST - 1 year ago

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences' TAEUS System

Feb 14, 2024, 8:30 AM EST - 1 year ago

ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and Europe

Nov 29, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology

Nov 27, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences to Participate in The Benchmark Company's 12th Annual Discovery One-on-One Investor Conference

Nov 14, 2023, 10:14 PM EST - 1 year ago

ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 1 year ago

ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 8:00 AM EST - 1 year ago

ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents

Nov 7, 2023, 4:05 PM EST - 1 year ago

ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

Nov 6, 2023, 8:00 AM EST - 1 year ago

ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD's The Liver Meeting® 2023

Sep 7, 2023, 8:00 AM EDT - 1 year ago

Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023

Aug 30, 2023, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA

Aug 23, 2023, 8:00 AM EDT - 1 year ago

ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents

Aug 14, 2023, 9:44 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript

Aug 14, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update

Aug 14, 2023, 1:30 PM EDT - 2 years ago

ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA

Aug 1, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023

Jul 6, 2023, 4:45 PM EDT - 2 years ago

ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023

Jun 7, 2023, 8:00 AM EDT - 2 years ago

Study Highlighting ENDRA Life Sciences' TAEUS Technology to be Presented at EASL International Liver Congress 2023

May 15, 2023, 9:48 PM EDT - 2 years ago

ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript

May 15, 2023, 4:05 PM EDT - 2 years ago

ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update

May 4, 2023, 8:00 AM EDT - 2 years ago

ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

May 2, 2023, 4:01 PM EDT - 2 years ago

ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Securities

jjstock99 Jun. 17 at 2:42 PM

$NDRA $CGBS Its coming ...

0 · Reply

LioGod Jun. 13 at 12:04 AM

$NDRA setting another pump?

0 · Reply

Bazzzigar Jun. 12 at 4:59 PM

$NDRA APDN WINT

0 · Reply

Lurker_Investor Jun. 10 at 5:36 AM

$NDRA This is fucked

0 · Reply

Jess_Inv Jun. 4 at 4:09 PM

$NDRA Patient wins ! Still waiting for volume to come in !

1 · Reply

johnlesser Jun. 4 at 4:03 PM

$NDRA Only takes a spark to get this fire going, which could turn into a volcano.

0 · Reply

ahTony Jun. 3 at 11:32 PM

$CDT $ALZN $PTIX $NDRA current sub 1 million float stocks on my watchlist.

0 · Reply

Molten_cpr Jun. 3 at 1:09 AM

$NDRA

0 · Reply

InvestorTechnical Jun. 2 at 4:48 PM

$NDRA remember me at $3.14 avg of 5,000 shares . Squeeze will happen and everyone pour in higher then me. $SPY $QQQ .. gonna be like a $PTIX when it ran to $14S from 3s

0 · Reply

Jess_Inv Jun. 2 at 4:03 PM

$NDRA $BEAM $NTLA bio tech are doing well today.

0 · Reply

TATTED_KEN May. 30 at 2:10 PM

$NDRA looks ready to rip. Waiting on $DXF $LIMN

0 · Reply

Notmyproblempal May. 30 at 1:29 PM

$NDRA mates. I don’t want to let you down but this company is all lies. They have been lying to their investors for a long time. Step back and look with reason.

2 · Reply

VolatileGems May. 30 at 11:47 AM

$NDRA buy rating, near bottom, absolutely worth a close watch to see if volume enters for upward momentum

0 · Reply

anachartanalyst May. 30 at 11:01 AM

$NDRA https://anachart.com/wp-content/uploads/ana_temp/1748602883_soc-img.jpg

0 · Reply

JarvisFlow May. 30 at 11:00 AM

Ascendiant Capital has adjusted their stance on ENDRA Life Sciences ( $NDRA ), setting the rating to Buy with a target price of 50 → 46.

0 · Reply

Jess_Inv May. 29 at 3:40 PM

$NDRA Volume is dead. Just added some here for a dead cat bounce.

0 · Reply

TATTED_KEN May. 29 at 2:14 PM

$DXF $LIMN levels to add before ppl start chasing this. Adding $NDRA low $3S

0 · Reply

InvestorTechnical May. 21 at 2:16 PM

$NDRA just like $PTIX from $3S to 10s sooner or later. 500k shares float , got no room to drop much. Any potential news boom!! I got in 5,000 shares at 3.14 avg! May see $2S but regardless not missing boat! I avg down , $10S will come . $SPY $QQQ

1 · Reply

InvestorTechnical May. 20 at 5:47 PM

$NDRA u finna get squeeze clown bears messing with 500k float and stochasticSlow slow curving up on SMA! But If u want your .01 to 20 cent u get it 🤣. Bet it see $10S soon ,

1 · Reply

Notmyproblempal May. 20 at 2:58 PM

$NDRA mates. They can’t even afford to update their investor presentation page. Go look. Still April of 2024. Bullocks!

0 · Reply

Notmyproblempal May. 20 at 2:56 PM

$NDRA you know this is a scam right?

0 · Reply

InvestorTechnical May. 20 at 12:36 PM

$PTIX y’all like this low float ran from $3S to 14$ ?! Then come join $NDRA it has 562k shares float! No room to drop much at all it seems $10S+ soon. Just like ptix ! $SPY $QQQ

0 · Reply

Market Cap	2.45M
Revenue (ttm)	0.00
Net Income (ttm)	-11.51M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	11,600
Avg Vol	207,808
Day's Range	N/A - N/A
Shares Out	738,000.00
Stochastic %K	11%
Beta	-0.21
Analysts	Sell
Price Target	$46.00